KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to -$75.9 million.

  • Exact Sciences' Cash from Financing Activities fell 82266.88% to -$75.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$338.1 million, marking a year-over-year decrease of 24580.76%. This contributed to the annual value of -$338.1 million for FY2025, which is 24580.76% down from last year.
  • Per Exact Sciences' latest filing, its Cash from Financing Activities stood at -$75.9 million for Q4 2025, which was down 82266.88% from -$1.5 million recorded in Q3 2025.
  • In the past 5 years, Exact Sciences' Cash from Financing Activities registered a high of $224.6 million during Q2 2024, and its lowest value of -$256.2 million during Q1 2025.
  • Moreover, its 5-year median value for Cash from Financing Activities was $1.5 million (2022), whereas its average is $6.9 million.
  • In the last 5 years, Exact Sciences' Cash from Financing Activities surged by 478468.01% in 2023 and then plummeted by 843334.44% in 2025.
  • Quarter analysis of 5 years shows Exact Sciences' Cash from Financing Activities stood at -$12.2 million in 2021, then surged by 182.84% to $10.1 million in 2022, then decreased by 0.65% to $10.0 million in 2023, then grew by 4.6% to $10.5 million in 2024, then crashed by 822.67% to -$75.9 million in 2025.
  • Its Cash from Financing Activities was -$75.9 million in Q4 2025, compared to -$1.5 million in Q3 2025 and -$4.5 million in Q2 2025.